Advertisement
BIO vs PEN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and PEN is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIO’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).
- BIO’s FA Score: 0 green, 5 red.
- PEN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIO’s TA Score shows that 4 TA indicator(s) are bullish while PEN’s TA Score has 3 bullish TA indicator(s).
- BIO’s TA Score: 4 bullish, 6 bearish.
- PEN’s TA Score: 3 bullish, 5 bearish.
Price Growth
BIO (@Medical/Nursing Services) experienced а -4.47% price change this week, while PEN (@Medical/Nursing Services) price change was -0.87% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.
Reported Earning Dates
BIO is expected to report earnings on Oct 23, 2025.
PEN is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Medical/Nursing Services (-1.97% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BIO | PEN | BIO / PEN | |
| Capitalization | 7.41B | 9.88B | 75% |
| EBITDA | 656M | 194M | 338% |
| Gain YTD | -17.418 | 6.691 | -260% |
| P/E Ratio | 24.47 | 67.03 | 37% |
| Revenue | 2.55B | 1.28B | 200% |
| Total Cash | 1.37B | 425M | 323% |
| Total Debt | 1.41B | 221M | 636% |
BIO | PEN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 88 | |
SMR RATING 1..100 | 86 | 63 | |
PRICE GROWTH RATING 1..100 | 56 | 56 | |
P/E GROWTH RATING 1..100 | 52 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PEN's Valuation (80) in the Medical Specialties industry is in the same range as BIO (82). This means that PEN’s stock grew similarly to BIO’s over the last 12 months.
PEN's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as BIO (100). This means that PEN’s stock grew similarly to BIO’s over the last 12 months.
PEN's SMR Rating (63) in the Medical Specialties industry is in the same range as BIO (86). This means that PEN’s stock grew similarly to BIO’s over the last 12 months.
PEN's Price Growth Rating (56) in the Medical Specialties industry is in the same range as BIO (56). This means that PEN’s stock grew similarly to BIO’s over the last 12 months.
BIO's P/E Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for PEN (100). This means that BIO’s stock grew somewhat faster than PEN’s over the last 12 months.
| BIO | PEN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 64% | 2 days ago 72% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 67% | 2 days ago 75% |
| Advances ODDS (%) | 22 days ago 70% | 18 days ago 79% |
| Declines ODDS (%) | 2 days ago 66% | 2 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 76% | N/A |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 69% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WINN | 30.90 | 0.13 | +0.41% |
| Harbor Long-Term Growers ETF | |||
| GNOV | 37.96 | 0.08 | +0.21% |
| FT Vest U.S. Eq Mod Buffr ETF - Nov | |||
| KNGZ | 35.29 | 0.03 | +0.09% |
| FirstTrust S&P500 DvrsDiv AristocratsETF | |||
| NXTI | 32.44 | N/A | N/A |
| Simplify Next Intangible Core Index ETF | |||
| LIAO | 206.55 | N/A | N/A |
| LifeX 2056 Infl-Prt Longevity Inc ETF | |||
BIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.
PEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BSX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To PEN | 1D Price Change % | ||
|---|---|---|---|---|
| PEN | 100% | +1.67% | ||
| BSX - PEN | 43% Loosely correlated | +0.04% | ||
| PODD - PEN | 42% Loosely correlated | -1.72% | ||
| ISRG - PEN | 41% Loosely correlated | +0.68% | ||
| GKOS - PEN | 37% Loosely correlated | -1.90% | ||
| BIO - PEN | 37% Loosely correlated | +0.35% | ||
More | ||||